NCT05792969

Brief Summary

This multi-center project aims to quantify the socio-medical costs associated with Unilateral Spatial Neglect (USN) resulting from acquired brain injury (stroke) and to measure the effects of USN rehabilitation on functional autonomy, quality of life and psychological well-being of patients affected by this syndrome, considering the repercussions on a psychological level and on the quality of life of caregivers. To this end, the experimenters will administer to right brain-injured patients - with (Experimental Group) or without (Control Group) USN - who undertook a rehabilitation process, a series of questionnaires: Activities of daily living (ADL), Barthel Index; Instrumental activities of daily living scale (I-ADL:), the Health Related Quality of Life questionnaire (EQ-5D-5L), the Geriatric Depression Scale (GDS), and the State-Trait Anxiety Inventory (STAI-Y). The aforementioned tests will be administered before the start of the rehabilitation (baseline) and after one month, 3, 6 and 12 months after the end of the rehabilitation. The impact of USN and its treatment on the psycho-physical well-being of the caregiver will be measured through the Caregiver Burden Inventory questionnaire, which will be administered with the same timing (baseline, 1-3-6-12 months after rehabilitation). The costs of USN will be surveyed through an ad-hoc questionnaire, which includes a version intended for patients and one for caregivers, in order to identify the resources consumed due to the disease and the expenses taken during the observation period, to be estimated subsequently in monetary terms (€).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
168

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 7, 2022

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

March 3, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

March 31, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
Last Updated

March 31, 2023

Status Verified

March 1, 2023

Enrollment Period

2.8 years

First QC Date

March 3, 2023

Last Update Submit

March 29, 2023

Conditions

Outcome Measures

Primary Outcomes (10)

  • Change in the Activities of Daily Living scale (ADL)

    To evaluate the degree of patients' functional independence in everyday life

    At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment

  • Change in the Instrumental Activities of Daily Living scale (I-ADL)

    To evaluate the degree of patients' functional independence instrumental activities, including, e.g., cleaning, cooking, and managing finances.

    At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment

  • Change in the Health-Related Quality of Life (EQ-5D-5L)

    A brief scale assessing patient's health-related quality of life

    At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment

  • Change in the Geriatric Depression Scale (GDS)

    A scale assessing patients' depressive symptoms

    At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment

  • Change in the State-Trait Anxiety Inventory (STAI-Y)

    A scale assessing patients' anxiety symptoms

    At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment

  • Change in the Caregiver Burden Inventory questionnaire (CBI)

    A scale that assess caregivers' physical and psychological burden

    At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment

  • Financial impact of USN

    A questionnaire about health-related costs associated to the disease (e.g., heath examinations, medicines, sick leaves)

    1 month after the end of the treatment

  • Financial impact of USN

    A questionnaire about health-related costs associated to the disease (e.g., heath examinations, medicines, sick leaves)

    3 months after the end of the treatment

  • Financial impact of USN

    A questionnaire about health-related costs associated to the disease (e.g., heath examinations, medicines, sick leaves)

    6 months after the end of the treatment

  • Financial impact of USN

    A questionnaire about health-related costs associated to the disease (e.g., heath examinations, medicines, sick leaves)

    12 months after the end of the treatment

Study Arms (2)

Stroke patients with USN and their caregivers

Behavioral: Functional measures and public health outcomes

Stroke patients without USN and their caregivers

Behavioral: Functional measures and public health outcomes

Interventions

Questionnaires: * Activities of daily living - ADL * Barthel Index * Instrumental activities of daily living- IADL * Health Related Quality of Life - EQ-5D-5L * Geriatric Depression Scale (GDS) * State-Trait Anxiety Inventory - STAI-Y) * Caregiver Burden Inventory questionnaire (CBI)

Stroke patients with USN and their caregiversStroke patients without USN and their caregivers

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Stroke patients with and without USN and their caregivers

You may qualify if:

  • age \> 18 years;
  • right brain injury due to stroke (of ischemic or hemorrhagic origin);
  • Disease duration ≥ 10 days;
  • Participation to a rehabilitation program;
  • For stroke patients with USN:
  • \- clinical diagnosis of USN, placed by the specialist of reference, on the basis of clinical indicators and the results obtained by the patient in the routine neuropsychological evaluation (by means of a battery of standardized psychometric tests calibrated in the Italian population).

You may not qualify if:

  • Other brain disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istituto Auxologico Italiano IRCCS

Milan, Lombardy, 20122, Italy

RECRUITING

Central Study Contacts

Nadia Bolognini, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2023

First Posted

March 31, 2023

Study Start

February 7, 2022

Primary Completion

November 30, 2024

Study Completion

November 30, 2024

Last Updated

March 31, 2023

Record last verified: 2023-03

Locations